Historique
Rapport
New regulatory regime for psychoactive substances. Regulatory impact statement and Cabinet paper
Auteur(s) :
New Zealand Ministry of Health ;
GRAY, D.
Année
2012
Page(s) :
28p.
Sous-type de document :
Rapport législatif / Legislative report
Langue(s) :
Anglais
Éditeur(s) :
Wellington : Ministry of Health of New Zealand
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
LOI (Loi et son application / Law enforcement)
Thésaurus géographique
NOUVELLE ZELANDE
Thésaurus mots-clés
DROGUES DE SYNTHESE
;
LEGISLATION
;
RECOMMANDATION
;
EVOLUTION
;
MARCHE DE LA DROGUE
;
BZP
;
DEFINITION
;
AMM
;
FABRICATION
;
TRAFIC INTERNATIONAL
Note de contenu :
This Regulatory Impact Analysis considers the proposed model and other options for how the regime might work. It covers the following issues:
• What the criteria for approval should be and what evidence would be required to meet approval standards (Part A)
• What the appropriate regulatory vehicle should be (Part B)
• What the process should be for the importation of psychoactive substances (Part C)
This paper also describes issues which the Ministry is still working on, namely:
• Offences and penalties (Part D)
• What the retail restrictions should be for approved products (Part E)
• Trade issues (Part F)
• What the criteria for approval should be and what evidence would be required to meet approval standards (Part A)
• What the appropriate regulatory vehicle should be (Part B)
• What the process should be for the importation of psychoactive substances (Part C)
This paper also describes issues which the Ministry is still working on, namely:
• Offences and penalties (Part D)
• What the retail restrictions should be for approved products (Part E)
• Trade issues (Part F)
Résumé :
This Regulatory Impact Statement has been prepared by the Ministry of Health.
Current legislation has proved ineffective in dealing with the rapid growth in new psychoactive substances, such as party pills and other legal highs, which can be synthesised to be one step ahead of existing controls. Cabinet has agreed to new legislation to address this by prohibiting the sale of all psychoactive substances unless approved by a regulator. The new legislation will reduce risks to the public by removing untested and potentially harmful products from being sold and introducing a pre-market approval scheme with testing requirements and retail restrictions for low-risk psychoactive substances.
The Cabinet Paper provides recommendations for the policy approach for the new regime, including the new regulator, funding, importation, legislative implementation, and separate report-backs on retail restrictions, fee-setting, and offences and penalties.
The Regulatory Impact Statement considers options for the approval criteria, the establishment of a regulator to carry out assessments and make approvals, and the process for importation.
Current legislation has proved ineffective in dealing with the rapid growth in new psychoactive substances, such as party pills and other legal highs, which can be synthesised to be one step ahead of existing controls. Cabinet has agreed to new legislation to address this by prohibiting the sale of all psychoactive substances unless approved by a regulator. The new legislation will reduce risks to the public by removing untested and potentially harmful products from being sold and introducing a pre-market approval scheme with testing requirements and retail restrictions for low-risk psychoactive substances.
The Cabinet Paper provides recommendations for the policy approach for the new regime, including the new regulator, funding, importation, legislative implementation, and separate report-backs on retail restrictions, fee-setting, and offences and penalties.
The Regulatory Impact Statement considers options for the approval criteria, the establishment of a regulator to carry out assessments and make approvals, and the process for importation.
Affiliation :
Nouvelle Zélande